Loading…
APO-TOPIRAMATE is a brand name for Topiramate, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
1 Pregnancy 12/2025 Table of Contents Sections or subsections that are not applicable at the time of authorization are not listed. Recent Major Label Changes....................................................................................................
2 Table of Contents .................................................................................................................... 2 Part 1: Healthcare Professional Information ............................................................................
5 1. Indications ........................................................................................................................................ 1. Pediatrics.............................................................................................................
2. Geriatrics ............................................................................................................. 5 2. Contraindications ..........................................................................................................
5 4. Dosage and Administration ........................................................................................... 1. Dosing Considerations ........................................................................................
2. Recommended Dose and Dosage Adjustment ..................................................... 4. Administration ................................................................................................... 5. Missed Dose.......................................................................................................
8 5. Overdose ....................................................................................................................... 9 6. Dosage Forms, Strengths, Composition and Packaging ..................................................
9 7. Warnings and Precautions ........................................................................................... 10 General ..............................................................................................................................
10 Carcinogenesis and Genotoxicity ....................................................................................... 10 Driving and Operating Machinery ......................................................................................
10 Endocrine and Metabolism ................................................................................................ 10 Hepatic/Biliary/Pancreatic .................................................................................................
15 Monitoring and Laboratory Tests ...................................................................................... 15 APO-TOPIRAMATE (topiramate tablets) Page 3 of 77 Unclassified / Non classifié Neurologic .........................................................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Topiramate in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
15 Ophthalmologic ................................................................................................................. 16 Psychiatric ..........................................................................................................................
17 Renal ................................................................................................................................. 17 Skin .................................................................................................................................
1. Special Populations................................................................................................... 1. Pregnancy ..............................................................................................................
2. Breast-feeding........................................................................................................ 3. Pediatrics ...............................................................................................................
4. Geriatrics................................................................................................................ 22 8. Adverse Reactions ........................................................................................................
1. Adverse Reaction Overview ...................................................................................... 2. Clinical Trial Adverse Reactions ................................................................................ 1.
Clinical Trial Adverse Reactions – Pediatrics ........................................................ 3. Less Common Clinical Trial Adverse Reactions ......................................................... 5. Post-Market Adverse Reactions ...............................................................................
39 9. Drug Interactions .......................................................................................................... 2. Drug Interactions Overview ......................................................................................
4. Drug-Drug Interactions ............................................................................................. 5. Drug-Food Interactions.............................................................................................
6. Drug-Herb Interactions ............................................................................................. 7. Drug-Laboratory Test Interactions............................................................................ 52 10.
Clinical Pharmacology […]